T-lymphocyte subpopulations and B7-H1/programmed death-1 (PD-1) positive lymphocytes infiltrating nasal polyps were evaluated in 17 patients with chronic sinusitis with nasal polyposis. Peripheral blood samples were also obtained from the patients and from 11 healthy controls. The CD4 + , CD8 + , CD3 + , CD19 + , B7-H1 + and PD-1 + lymphocyte populations were measured using flow cytometry. Lymphocytes from nasal polyps had significantly fewer CD4 + but significantly more CD8 + T-cells compared with lymphocytes from the peripheral blood of patients and controls.
Introduction
Bilateral nasal polyposis is a form of chronic sinusitis characterized by chronic inflammatory disease of the mucosa of the nasal cavity and paranasal sinuses. 1 The overall prevalence of nasal polyposis in the general population ranges from 1% to 4%. 1 Quality of life for nasal polyposis patients is worse than for patients with hypertension, migraine, angina pectoris, or head and neck cancer. 2 Although some hypotheses exist for how nasal polyposis develops, the aetiopathologenetic mechanisms of the disease remain controversial. 1, 3 The pathogenesis of chronic sinusitis with nasal polyposis (CRSwNP) is thought to involve persistent inflammation of the nasal mucosa due to infiltration by eosinophils and other cell types (lymphocytes, mast cells, basophils and neutrophils). 1 Nasal polyposis is histologically characterized by respiratory epithelium covering oedematous stroma, which is infiltrated by inflammatory cells. 1 It has been shown that eosinophils and lymphocytes are the most common inflammatory cells in nasal polyposis. 4 Tlymphocytes are central to the development of sinonasal inflammation. The initiation and regulation of nasal inflammatory responses are absolutely dependent on Tlymphocyte recruitment, activation and cytokine secretion, which may contribute to eosinophil recruitment and activation. 5 The factors that regulate these aspects of T-cell function are not completely understood, but may include engagement of T-cell-specific accessory molecules.
For efficient T-cell activation, T-cells require both a T-cell receptor-mediated antigen (Ag)-specific signal and costimulatory signals provided by antigenpresenting cells (APCs). Several different types of leucocytes can act as APCs, including dendritic cells, macrophages and B-cells. The B7 family of molecules provides signals that are critical both for stimulating and for inhibiting T-cell activation, and interaction between B7 and CD28 may determine whether a T-cell response develops. 6 T-cell activation occurs as the result of a balance between positive and negative signals. The inducible co-stimulator molecule and CD28 are positive costimulatory receptors that interact with the ligands of the B7 family present on APCs and are essential for the activation and proliferation of antigen-specific T-cells. 6 In contrast, negative signals through cell surface molecules, such as cytotoxic Tlymphocyte antigen 4 and programmed death-1 (PD-1), inhibit T-cell activation or induce apoptosis. 6 Several members of the B7 family have now been identified. One of these, B7-H1, binds to the PD-1 receptor and their interaction down-regulates T-cell activation. 6, 7 PD-1 is a type I transmembrane receptor that is expressed on activated T-and B-cells; like cytotoxic T-lymphocyte antigen-4, PD-1 contains an immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic region and it acts as a negative regulator of lymphocyte function. 6 Several studies support the concept that the B7-H1/PD-1 pathway plays an important immunoregulatory role in the chronicity of inflammatory disorders. 6, 7 In addition, CRSwNP is considered to be an ultimate manifestation of chronic inflammation; therefore, the B7-H1/PD-1 pathway may contribute to CRSwNP. Although Kim et al. 8 have studied B7-H1 expression in nasal epithelial cells, very few studies have examined the expression of the B7-H1/PD-1 pathway in nasal polyposis lymphocytes. 9 The aim of the present study was to determine whether there were changes in the T-lymphocyte subpopulations and levels of B7-H1 and PD-1 positive lymphocytes infiltrating nasal polyps, which may contribute to the development of the chronic inflammation associated with nasal polyposis. 
Patients and methods PATIENTS
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modified Lund and Mackay CT score of ≥ 18 was required for inclusion in this study. 10 None of the patients had received oral or intranasal steroids for at least 4 weeks before surgery. Patients with allergy, asthma, aspirin intolerance, cystic fibrosis, an immunocompromised status, or ciliary dyskinesia were excluded from the study. The atopic status was assessed by skin prick tests to common inhalant allergens and radioallergosorbent tests.
Normal mucosal biopsy controls were not taken because a previous study 11 had demonstrated that the number of lymphocytes obtained is so small that reliable studies cannot be accurately performed with these samples. Peripheral blood lymphocytes from the same CRSwNP patients were studied and compared with nasal polyposis lymphocytes. In addition, the peripheral blood lymphocytes of the healthy controls were studied and compared with those of the patients with CRSwNP.
HISTOLOGICAL TECHNIQUES
All tissues were fixed overnight in 10% formalin and then subjected to routine paraffin embedding. Sections 4 µm thick were cut and placed on slides before being stained for histological examination using haematoxylin and eosin.
FLOW CYTOMETRY
Blood was drawn from a peripheral vein of each subject into heparinized syringes and processed on the day of collection. The following antibody combinations were added to 100 µl of peripheral blood and incubated for 30 min at room temperature in the dark: fluorescein isothiocyanate (FITC)conjugated CD4 and phycoerythrin (PE)conjugated CD8 (BD Biosciences, San Jose, CA, USA); FITC-conjugated CD19 (BD Biosciences) and PE-conjugated B7-H1 (eBioscience, San Diego, CA, USA); FITCconjugated CD3 (BD Biosciences) and allophycocyanin (APC)-conjugated PD-1(eBioscience); or isotype immunoglobulin (Ig)G-PE (eBioscience). Red blood cell lysis buffer (eBioscience; 4 ml) was added to the samples and incubated at room temperature for 10 min. Cells were harvested by centrifugation for 5 min at 300 g and the supernatant was discharged. Cells were washed with 10 ml of 0.01 M phosphatebuffered saline (PBS) at pH 7.4, harvested by centrifugation for 5 min at 300 g, and the cell pellet was then resuspended in 1% formaldehyde/0.01 M PBS for storage prior to fluorescence-activated cell sorting (FACS) analysis.
To obtain tissue lymphocytes, fresh surgical specimens of nasal polyps were immediately incubated in RPMI 1640 medium (Gibco ® , Carlsbad, CA, USA) with 10% fetal calf serum (Gibco ® ) and digested with 0.25% trypsin for 10 min. The nasal polyp tissues were then cut into small pieces with dissecting scissors.
Single-cell suspensions were prepared by squashing with 350 micron opening nylon mesh, and cells were harvested by centrifugation for 5 min at 300 g. Cells were labelled with antibodies using the same methods as already described for peripheral blood cells and then resuspended in 0.01 M PBS before FACS analysis.
Analyses were performed on a FACScalibur™ flow cytometer (BD Biosciences) using CellQuest™ software (BD Biosciences). For each sample, at least 10 000 events were collected and histograms were generated.
STATISTICAL ANALYSES
The means ± SE for the data were calculated and statistical analyses were performed using the SPSS ® statistical package, version LP Zhang, L Lin, CQ Zheng et al. T-lymphocyte subpopulations and B7-H1/PD-1 expression 12 .0 (SPSS Inc., Chicago, IL, USA) for Windows ® . The χ 2 test and Student's t-test were used for comparison between groups. If variances in groups were not homogeneous, the non-parametric Mann-Whitney U-test was used. A P-value < 0.05 was considered to be statistically significant.
Results
A total of 17 patients with CRSwNP and 11 sex-and age-matched healthy control subjects were included in this study. Based on the histological characteristics, nine CRSwNP cases were of the eosinophilic type ( Fig. 1A ) and eight cases were of the chronic inflammatory type characterized by a large number of inflammatory cells, mainly lymphocytes with fewer eosinophils (Fig. 1B) .
Standard flow cytometric plots of T-cell and B-cell subpopulations and B7-H1 and PD-1 positive lymphocytes from nasal polyp and peripheral blood samples from CRSwNP patients and from healthy controls are shown in Fig. 2A . The mean ± SE percentage of CD4 + cells in nasal polyps and peripheral blood from CRSwNP patients and in peripheral blood from healthy control samples was 24.01 ± 9.20%, 39.61 ± 7.41% and 36.25 ± 5.87%, respectively (Fig. 2B) , for CD8 + cells the values were 37.86 ± 6.79%, 28.71 ± 4.30% and 30.50 ± 3.11%, respectively (Fig. 2C) , and the CD4/CD8 ratios were 0.70 ± 0.43, 1.42 ± 0.40 and 1.20 ± 0.20, respectively. The nasal polyp lymphocyte samples from CRSwNP patients had significantly fewer CD4 + T-cells but significantly more CD8 + T-cells in comparison with the peripheral blood samples from patients and healthy controls (P < 0.01). There were no significant differences in the numbers of CD4 + or CD8 + cells in peripheral blood from patients versus healthy controls.
The mean ± SE percentage of CD19 + Bcells expressing B7-H1 in nasal polyps and peripheral blood from CRSwNP patients and in peripheral blood from healthy control samples was 13.32 ± 6.26%, 4.68 ± 1.8% and 0.98 ± 0.28%, respectively (Fig. 2D) . The mean ± SE percentage of CD19 + B-cells expressing B7-H1 was significantly higher in nasal polyp samples than in the peripheral blood of the patient and healthy control samples (P < 0.01) and was also significantly The mean percentage ± SE of CD3 + T-cells expressing PD-1 in nasal polyps and peripheral blood from CRSwNP patients and in peripheral blood from healthy control samples was 38.17 ± 12.18%, 10.72 ± 2.98% and 4.21 ± 1.27%, respectively (Fig. 2E) . The mean ± SE percentage of CD3 + T-cells expressing PD-1 was significantly higher in the nasal polyp samples than in the peripheral blood of the patient and healthy control samples (P < 0.01), and was also significantly higher in peripheral blood samples from CRSwNP patients than in peripheral blood from healthy control samples (P < 0.01).
Discussion
Although multiple host and environmental factors have been implicated in the aetiology The mean percentage ± SE of (B) CD4 + T-cells was significantly lower and of (C) CD8 + T-cells was significantly higher in nasal polyp samples from patients with chronic sinusitis with nasal polyposis (CRSwNP) compared with peripheral blood from CRSwNP patients and healthy controls (**P < 0.01). The mean percentage ± SE of (D) CD19 + B7-H1 + B-cells expressing B7-H1 and of (E) CD3 + PD-1 + T-cells expressing PD-1 was significantly higher in nasal polyp samples from CRSwNP patients compared with peripheral blood from CRSwNP patients and healthy controls (**P < 0.01), and also significantly higher in peripheral blood samples from CRSwNP patients compared with healthy controls ( † † P < 0.01) ( 
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of idiopathic CRSwNP and the aetiology remains a matter of vigorous debate, 12 it is clear that nasal polyposis is primarily a disorder of persistent inflammation. Since inflammation is normally a self-limiting process, 'chronicity' of inflammation results from either the persistence of a stimulus, for example a micro-organism or allergen, or from dysregulation of the endogenous antiinflammatory mechanisms that normally co-ordinate resolution. The sinonasal cavity is constantly exposed to foreign particulates, antigens and potential pathogens such as viruses, fungi and bacteria, because it is the first site of contact for many airborne particulates and micro-organisms entering the body. Although many innate immune mechanisms exist to eliminate potential pathogens before they reach the epithelial cell surface, antigens encountered in the nasal lumen are routinely sampled by the mucosa for evaluation by the adaptive immune system. In the sinonasal tract, the acquired immune response involves the activation of antigen-specific B-and Tlymphocytes which initiate and maintain the local immune response. 11 Once the immune responses targeting the invading pathogen are established, the host cells usually up-regulate a set of regulatory molecules that protect themselves from further or unwanted injury by those immune responses that were originally aimed at the immunogenic antigens. As discussed previously, current studies have focused on identification of the predominant, presumably microbial, agents which initiate CRSwNP rather than searching for putative defects in the host response that might contribute to the development of CRSwNP. 3, 13, 14 Emerging evidence has suggested that, in many instances, aberrant host immune responses, rather than pathogen-specific toxins, are the real pathogenic factors that cause the disease or function as its risk factors. 6, 7 In this context, it is critical to identify the defects in the immune response of patients, in addition to identifying unique environmental agents that contribute to the development of CRSwNP.
One of the B7 family members of costimulatory molecules that regulate T-cell responses is B7-H1 (also called CD274 or PD-L1). Although the expression of B7-H1 is limited to a small fraction of haematopoietic cells, it is largely inducible in various nonlymphoid tissues and cells. 6, 8, 9 The CD28 family member, PD-1, is inducibly expressed on activated T-cells, B-cells and monocytes, and it is likely that it regulates these cell types. 6 Although the precise role of the B7-H1/PD-1 pathway in the regulation of T-cell function in inflammation and autoimmunity remains a topic for further investigation, the B7-H1/PD-1 pathway has consistently been reported to play an important role in regulating T-cell activation and peripheral tolerance. 6,15 -17 In the present study, B7-H1 and PD-1 were significantly up-regulated in lymphocytes from nasal polyps of CRSwNP patients in comparison with lymphocytes from the peripheral blood of both CRSwNP patients and healthy controls. The up-regulation of B7-H1 on CD19 + B-cells, and PD-1 on CD3 + Tcells suggests that the B7-H1/PD-1 pathway may act to modulate immune responses in CRSwNP patients. Currently, CD19 is the main marker used to identify human B-cells that can act as APCs. B-cells do not normally express co-stimulatory molecules such as B7-H1, but their expression is induced by pathogenic exposure. 6 Although the role of infectious agents in the development of CRSwNP remains unclear, studies have implicated toxigenic Staphylococcus aureus bacteria and Alternaria fungi in CRSwNP LP Zhang, L Lin, CQ Zheng et al.
pathogenesis. 3, 18 The peripheral blood lymphocytes from patients with CRS release more interferon-γ (IFN-γ) when cultured with fungal extracts than normal controls. 13 Douglas et al. 19 have further demonstrated that staphylococcal superantigen type B (SEB) increased the expression of IFN-γ in peripheral blood lymphocytes, and this effect was magnified by the addition of both SEB and fungal extracts to the culture medium. Lymphocytes producing IFN-γ have been identified in nasal polyposis. 5, 11 IFN-γ is a multifunctional cytokine and a strong inducer of B7-H1 expression. 16 It has been found that B7-H1 expression of primary nasal epithelial cells can be selectively induced by IFN-γ and that human rhinovirus 16 infection induced the expression of B7-H1 on human airway epithelial cells. 8, 9 Together, these observations raise the possibility that secretion of high levels of IFN-γ by activated T-cells upon stimulation increases B7-H1 levels on the surface of Bcells and causes a down-regulation of T-cell responses, resulting in a negative feedback loop in nasal polyposis. Molecular defects in the B7-H1/PD-1 pathway could, therefore, be responsible for impairment of the immunoregulatory balance of the inflammatory response in nasal polyposis patients. The reason for this phenomenon is not clear, but data from the present study suggest that nasal polyposis could represent a state in which B7-H1 and PD-1 are induced as a response to chronic inflammation within the nasal mucosa. We surmise that significant B7-H1/PD-1 co-stimulatory molecule up-regulation in CRSwNP patients may eventually delay the T-cell response, result in a failure to clear pathogens from the sinuses and lead to a chronic inflammatory state due to bacterial, viral or fungal re-exposure.
Another interesting result of the present study was the difference in the percentages of B-cells expressing B7-H1, T-cells expressing PD-1 and CD4/CD8 ratios between lymphocytes samples taken from nasal polyps and from peripheral blood in CRSwNP patients. These were similar to previously published findings that showed that there were significant differences between levels of cytokines produced by the T-cells from nasal polyps and peripheral blood. 5, 11 The organization of the secondary lymphoid tissue within the nasal polyp tissue may contribute to the dissociation between the total IgE, IgG and IgA antibodies in the serum and nasal polyp tissue. 20, 21 Nasal polyposis is a unique mucosal chronic inflammation of nasal polyp tissue in which a specialized local immune subsystem may exist. The peripheral blood lymphocytes probably reach the nasal polyp tissue. The lymphocytes of the local mucosal immune system also reach the lamina propria of the polyps as a result of migration of lymphoid cells from mucosa-associated lymphoid tissue (MALT), which comprises the adenoids, paired palatine tonsil, and other smaller lymphoid structures of Waldeyer's pharyngeal ring. 22 The mucosal immune system is more complex than its systemic counterpart. MALT is populated by phenotypically and functionally distinct Bcells, T-cells and accessory cell subpopulations from those in systemic lymphoid tissues. 22 MALT also has limited recirculation of lymphoid cells between mucosal sites. 23 Data from the present study were in agreement with the concept of Bernstein et al. 11 that nasal polyp lymphocyte subpopulations may originate from both the local mucosal immune system and from random migration of peripheral blood lymphocytes. These findings also suggest that a specialized local mucosal immune subsystem may be In conclusion, the present study, which was based on a small number of subjects with severe bilateral diffuse nasal polyps, demonstrated changes in the T-lymphocyte subpopulations and up-regulation of B7-H1 and PD-1 in lymphocytes infiltrating the nasal polyps. These changes may be involved in development of the chronic inflammation associated with nasal polyposis. These results require confirmation in a larger study, however since it is difficult to obtain adequate numbers of lymphocytes from non-polyp sinonasal tissue, a different technique will need to be used. The mechanisms underlying the up-regulation of B7-H1 and PD-1 will be addressed in future studies.
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